{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T17:40:46Z","timestamp":1652895646537},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T00:00:00Z","timestamp":1437523200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s11255-015-1056-3","type":"journal-article","created":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T10:18:33Z","timestamp":1437473913000},"page":"1565-1570","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Anti-platelet factor 4\/heparin antibody is associated with progression of peripheral arterial disease in hemodialysis patients"],"prefix":"10.1007","volume":"47","author":[{"given":"Yen-Hsun","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kao-Chang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueh-Feng","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lai-King","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Hsueh","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-An","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,22]]},"reference":[{"key":"1056_CR1","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/ndt\/gfh544","volume":"20","author":"M Haase","year":"2005","unstructured":"Haase M, Bellomo R, Rocktaeschel J et al (2005) Use of fondaparinux (arixtra) in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type ii. Nephrol Dial Transplant 20:444\u2013446","journal-title":"Nephrol Dial Transplant"},{"key":"1056_CR2","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1182\/blood-2008-02-078014","volume":"112","author":"JG Kelton","year":"2008","unstructured":"Kelton JG, Warkentin TE (2008) Heparin-induced thrombocytopenia: a historical perspective. Blood 112:2607\u20132616","journal-title":"Blood"},{"key":"1056_CR3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/intimm\/14.2.121","volume":"14","author":"M Blank","year":"2002","unstructured":"Blank M, Shoenfeld Y, Tavor S et al (2002) Anti-platelet factor 4\/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells. Int Immunol 14:121\u2013129","journal-title":"Int Immunol"},{"key":"1056_CR4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ki.5002631","volume":"73","author":"M Carrier","year":"2008","unstructured":"Carrier M, Rodger MA, Fergusson D et al (2008) Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex. Kidney Int 73:213\u2013219","journal-title":"Kidney Int"},{"key":"1056_CR5","doi-asserted-by":"crossref","first-page":"874","DOI":"10.2215\/CJN.01170209","volume":"5","author":"V Krane","year":"2010","unstructured":"Krane V, Berger M, Lilienthal J, Winkler K, Schambeck C, Wanner C (2010) Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes. Clin J Am Soc Nephrol 5:874\u2013881","journal-title":"Clin J Am Soc Nephrol"},{"key":"1056_CR6","doi-asserted-by":"crossref","first-page":"995","DOI":"10.4065\/80.8.995","volume":"80","author":"L Pena de la Vega","year":"2005","unstructured":"Pena de la Vega L, Miller RS, Benda MM et al (2005) Association of heparin-dependent antibodies and adverse outcomes in hemodialysis patients: a population-based study. Mayo Clin Proc 80:995\u20131000","journal-title":"Mayo Clin Proc"},{"key":"1056_CR7","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296\u20131305","journal-title":"N Engl J Med"},{"key":"1056_CR8","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/CIRCULATIONAHA.105.593442","volume":"114","author":"BA Golomb","year":"2006","unstructured":"Golomb BA, Dang TT, Criqui MH (2006) Peripheral arterial disease: morbidity and mortality implications. Circulation 114:688\u2013699","journal-title":"Circulation"},{"key":"1056_CR9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.105.570903","volume":"113","author":"AM O\u2019Hare","year":"2006","unstructured":"O\u2019Hare AM, Katz R, Shlipak MG, Cushman M, Newman AB (2006) Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the cardiovascular health study. Circulation 113:388\u2013393","journal-title":"Circulation"},{"key":"1056_CR10","doi-asserted-by":"crossref","first-page":"V303","DOI":"10.1016\/S0049-3848(01)00366-8","volume":"106","author":"JL Halperin","year":"2002","unstructured":"Halperin JL (2002) Evaluation of patients with peripheral vascular disease. Thromb Res 106:V303\u2013V311","journal-title":"Thromb Res"},{"key":"1056_CR11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.atherosclerosis.2011.09.037","volume":"219","author":"M Tanaka","year":"2011","unstructured":"Tanaka M, Ishii H, Aoyama T et al (2011) Ankle brachial pressure index but not brachial-ankle pulse wave velocity is a strong predictor of systemic atherosclerotic morbidity and mortality in patients on maintenance hemodialysis. Atherosclerosis 219:643\u2013647","journal-title":"Atherosclerosis"},{"key":"1056_CR12","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1053\/j.ajkd.2005.06.016","volume":"46","author":"T Kitahara","year":"2005","unstructured":"Kitahara T, Ono K, Tsuchida A et al (2005) Impact of brachial-ankle pulse wave velocity and ankle-brachial blood pressure index on mortality in hemodialysis patients. Am J Kidney Dis 46:688\u2013696","journal-title":"Am J Kidney Dis"},{"key":"1056_CR13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000102052","volume":"35","author":"T Matsuo","year":"2006","unstructured":"Matsuo T, Kobayashi H, Matsuo M et al (2006) Frequency of anti-heparin-PF4 complex antibodies (hit antibodies) in uremic patients on chronic intermittent hemodialysis. Pathophysiol Haemost Thromb 35:445\u2013450","journal-title":"Pathophysiol Haemost Thromb"},{"key":"1056_CR14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jcla.20076","volume":"19","author":"I Palomo","year":"2005","unstructured":"Palomo I, Pereira J, Alarcon M et al (2005) Prevalence of heparin-induced antibodies in patients with chronic renal failure undergoing hemodialysis. J Clin Lab Anal 19:189\u2013195","journal-title":"J Clin Lab Anal"},{"key":"1056_CR15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000045044","volume":"79","author":"T Sitter","year":"1998","unstructured":"Sitter T, Spannagl M, Banas B, Schiffl H (1998) Prevalence of heparin-induced PF4-heparin antibodies in hemodialysis patients. Nephron 79:245\u2013246","journal-title":"Nephron"},{"key":"1056_CR16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1681\/ASN.V132497","volume":"13","author":"AM O\u2019Hare","year":"2002","unstructured":"O\u2019Hare AM, Hsu CY, Bacchetti P, Johansen KL (2002) Peripheral vascular disease risk factors among patients undergoing hemodialysis. J Am Soc Nephrol 13:497\u2013503","journal-title":"J Am Soc Nephrol"},{"key":"1056_CR17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1755.2000.00173.x","volume":"58","author":"AK Cheung","year":"2000","unstructured":"Cheung AK, Sarnak MJ, Yan G et al (2000) Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 58:353\u2013362","journal-title":"Kidney Int"},{"key":"1056_CR18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s10157-011-0555-5","volume":"16","author":"YF Tsai","year":"2012","unstructured":"Tsai YF, Chen CA, Kuo C, Lin KC (2012) Anti-PF4\/heparin antibodies are associated with arteriovenous fistula thrombosis in non-diabetic hemodialysis patients. Clin Exp Nephrol 16:300\u2013305","journal-title":"Clin Exp Nephrol"},{"key":"1056_CR19","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2215\/CJN.04101206","volume":"2","author":"SS DeLoach","year":"2007","unstructured":"DeLoach SS, Mohler ER 3rd (2007) Peripheral arterial disease: a guide for nephrologists. Clin J Am Soc Nephrol 2:839\u2013846","journal-title":"Clin J Am Soc Nephrol"},{"key":"1056_CR20","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1160\/TH08-01-0048","volume":"100","author":"LM Asmis","year":"2008","unstructured":"Asmis LM, Segal JB, Plantinga LC et al (2008) Heparin-induced antibodies and cardiovascular risk in patients on dialysis. Thromb Haemost 100:498\u2013504","journal-title":"Thromb Haemost"},{"key":"1056_CR21","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1160\/TH08-02-0118","volume":"100","author":"NL Whitlatch","year":"2008","unstructured":"Whitlatch NL, Perry SL, Ortel TL (2008) Anti-heparin\/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 100:678\u2013684","journal-title":"Thromb Haemost"},{"key":"1056_CR22","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1161\/01.ATV.0000246775.14471.26","volume":"26","author":"O Morel","year":"2006","unstructured":"Morel O, Toti F, Hugel B et al (2006) Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 26:2594\u20132604","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1056_CR23","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/ndt\/gfq858","volume":"26","author":"E Neven","year":"2011","unstructured":"Neven E, De Schutter TM, Behets GJ, Gupta A, D\u2019Haese PC (2011) Iron and vascular calcification. Is there a link? Nephrol Dial Transplant 26:1137\u20131145","journal-title":"Nephrol Dial Transplant"},{"key":"1056_CR24","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jvs.2010.09.070","volume":"53","author":"T Ohtake","year":"2011","unstructured":"Ohtake T, Oka M, Ikee R et al (2011) Impact of lower limbs\u2019 arterial calcification on the prevalence and severity of pad in patients on hemodialysis. J Vasc Surg 53:676\u2013683","journal-title":"J Vasc Surg"},{"key":"1056_CR25","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/sj.ki.5002696","volume":"73","author":"M Schoppet","year":"2008","unstructured":"Schoppet M, Shroff RC, Hofbauer LC, Shanahan CM (2008) Exploring the biology of vascular calcification in chronic kidney disease: what\u2019s circulating? Kidney Int 73:384\u2013390","journal-title":"Kidney Int"},{"key":"1056_CR26","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1161\/CIRCULATIONAHA.105.607390","volume":"114","author":"S Rajagopalan","year":"2006","unstructured":"Rajagopalan S, Dellegrottaglie S, Furniss AL et al (2006) Peripheral arterial disease in patients with end-stage renal disease: observations from the dialysis outcomes and practice patterns study (DOPPS). Circulation 114:1914\u20131922","journal-title":"Circulation"},{"key":"1056_CR27","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","volume":"105","author":"P Libby","year":"2002","unstructured":"Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105:1135\u20131143","journal-title":"Circulation"},{"key":"1056_CR28","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/hq1101.098486","volume":"21","author":"M Takemoto","year":"2001","unstructured":"Takemoto M, Liao JK (2001) Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol 21:1712\u20131719","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1056_CR29","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/01.CIR.0000050380.64025.07","volume":"107","author":"MM McDermott","year":"2003","unstructured":"McDermott MM, Guralnik JM, Greenland P et al (2003) Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease. Circulation 107:757\u2013761","journal-title":"Circulation"},{"key":"1056_CR30","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1093\/eurheartj\/ehu080","volume":"35","author":"DJ Kumbhani","year":"2014","unstructured":"Kumbhani DJ, Steg PG, Cannon CP et al (2014) Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the reach registry. Eur Heart J 35:2864\u20132872","journal-title":"Eur Heart J"},{"key":"1056_CR31","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ehj.2004.02.012","volume":"25","author":"M Schillinger","year":"2004","unstructured":"Schillinger M, Exner M, Mlekusch W et al (2004) Statin therapy improves cardiovascular outcome of patients with peripheral artery disease. Eur Heart J 25:742\u2013748","journal-title":"Eur Heart J"},{"key":"1056_CR32","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","volume":"353","author":"C Wanner","year":"2005","unstructured":"Wanner C, Krane V, Marz W et al (2005) Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353:238\u2013248","journal-title":"N Engl J Med"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-015-1056-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-015-1056-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-015-1056-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T17:15:28Z","timestamp":1652894128000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-015-1056-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,22]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["1056"],"URL":"https:\/\/doi.org\/10.1007\/s11255-015-1056-3","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,22]]}}}